Logo
Search

Rules:

Only words with 2 or more characters are accepted
Max 200 chars total
Space is used to split words, "" can be used to search for a whole string (not indexed search then)
AND, OR and NOT are prefix words, overruling the default operator
+/|/- equals AND, OR and NOT as operators.
All search words are converted to lowercase.

Search for "therapeutic"

Displaying results 1 to 7 out of 7

  Berlin 81%
  ... has gained significant expertise in implementing human pharmacological trials with cardiovascular drugs, contrast agents and specialised therapeutics in all common designs. Thus, CRS-Berlin can realize a wide range of study types supported by a database with a diversity of volunteer ... as various laboratories for immediate blood and urine processing. History The unit was originally established in 1988 as a merger of different
  Size: 33 K - Created: 02-07-13 - Modified: 20-06-17 17:09
Path: /Locations/Berlin

  1981 – 1989 80%
  ... IV. World Conference on Clinical Pharmacology & Therapeutics, Mannheim-Heidelberg, July 23-28, 1989 Ulmer, J., ... IV. World Conference on Clinical Pharmacology & Therapeutics, Mannheim-Heidelberg, July 23-28, 1989. Hasibeder, ... agent. IV World Conference on Clinical Pharmacology & Therapeutics, Mannheim-Heidelberg, 23-28 July 1989. Euro J Clin ...
  Size: 41 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/1981 – 1989

  Medical Writing 78%
  ... Medicinal Product Dossier (IMPD)   Clinical and non-clinical summaries and overviews of Common Technical Documents (CTD)   Development and therapeutic areas: Phase I Clinical pharmacology studies – pharmacokinetics and pharmacodynamics Biologics and biosimilars
  Size: 32 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Services/Medical Writing

  2010-2017 73%
  ... Kuijk J, Lillin O, Post T, Thomsen T . The Effect of Therapeutic and Supratherapeutic Oral Doses of Nomegestrol Acetate ... ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study. Clin Exp ... increases thrombelastography parameters at therapeutic plasma concentrations as measured with ROTEM® - a ...
  Size: 65 K - Created: 09-11-15 - Modified: 27-07-17 10:05
Path: /Expertise/Published Expertise/2010-2017

  1990 – 1999 71%
  ... (AO-128). Acta Physiologica Pharmacologica et Therapeutica Latinoamericano 1996 ; P 242 No. 556. Ehrlich A, ... subjects. Acta Physiologica Pharmacologica et Therapeutica Latinoamericano 1996 ; 242 No. 555. Rehn D, Unkauf ... of the German Society for Clinical Pharmacology and Therapeutics, Dresden, 5-7 September 1996. Abstract: Eur J Clin ... U, Thomsen T , Engel RR. Galanthamine as a useful
  Size: 61 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/1990 – 1999

  Trial Expertise 69%
  ... of beneficial effects and to enhance the prevention of negative effects from drug therapy. Because genetic factors affect human responses to therapeutic drugs, CRS has access to a broad range of genotyped subjects . Thorough QTc/cardiac safety CRS has conducted 19 trials with cardiac safety ...
  Size: 35 K - Created: 18-11-12 - Modified: 20-06-17 17:09
Path: /Expertise/Trial Expertise

  2000 – 2009 61%
  ... J Clin Pharmacol 2009; 49(4):455-464. Erpenbeck VJ, Fischer I, Wiese K, Schaumann F , Schmiedl A, Nassenstein C, Krug N, Hohlfeld JM. Therapeutic surfactants modulate the viability of eosinophils and induce inflammatory mediator release Int Arch Allergy Immunol 2009; Epub 2009 Mar 17. ... of a “Suprabioavailable” Formulation of Fenofibrate in Patients with Dyslipidemia : A Pooled Analysis of Two Open-Label Trials.  Clinical
  Size: 53 K - Created: 09-11-15 - Modified: 20-06-17 17:09
Path: /Expertise/Published Expertise/2000 – 2009

FooterEnd